Mood Disorders

The grounding supports a multifactorial etiology rather than a single cause. Reported contributors include stress-related neurobiology, circadian rhythm disruption, and shared inflammatory pathways in comorbid disease contexts; the literature also notes that the pathogenesis remains incompletely understood.

The literature emphasizes altered brain circuits involved in emotional regulation, including the medial prefrontal cortex, amygdala, hippocampus, and ventromedial basal ganglia. It also describes changes in grey matter volume and neurophysiological activity, along with disrupted circadian clock-controlled responses and stress-related effects on neuroplasticity.

Circadian disruption is a supported risk factor, including jet lag, night-shift work, and exposure to artificial light at night. The grounding also indicates susceptibility in individuals exposed to ongoing stress and suggests shared inflammatory and genetic factors in some comorbid settings.

Treatment is described at the modality level as psychiatric management for mood disorders, with current care noted to be suboptimal in many cases. The supplied review literature also discusses psychedelic-assisted approaches, including lysergic acid diethylamide and psilocybin, as investigational or studied treatments in medically controlled environments rather than established routine care.